Global Injection Pen Market 2024-2028

Description

List of Tables

The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.

Technavio's injection pen market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	7.54%
CAGR	8.13%
Incremental Value	$25.51bn

By Product

Growth hormone
Diabetes
Fertility
Osteoporosis
Others

By Type

Disposable injection pen
Reusable injection pen

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market vendors and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:

Injection pen market sizing
Injection pen market forecast
Injection pen market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71195

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global injection pen market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Growth hormone - Market size and forecast 2023-2028
Exhibit 34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
6.4 Diabetes - Market size and forecast 2023-2028
Exhibit 38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
6.5 Fertility - Market size and forecast 2023-2028
Exhibit 42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
6.6 Osteoporosis - Market size and forecast 2023-2028
Exhibit 46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 56: Chart on Type - Market share 2023-2028 (%)
Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
7.3 Disposable injection pen - Market size and forecast 2023-2028
Exhibit 60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
7.4 Reusable injection pen - Market size and forecast 2023-2028
Exhibit 64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ billion)
Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AstraZeneca Plc
Exhibit 119: AstraZeneca Plc - Overview
Exhibit 120: AstraZeneca Plc - Product / Service
Exhibit 121: AstraZeneca Plc - Key news
Exhibit 122: AstraZeneca Plc - Key offerings
12.4 Becton Dickinson and Co.
Exhibit 123: Becton Dickinson and Co. - Overview
Exhibit 124: Becton Dickinson and Co. - Business segments
Exhibit 125: Becton Dickinson and Co. - Key news
Exhibit 126: Becton Dickinson and Co. - Key offerings
Exhibit 127: Becton Dickinson and Co. - Segment focus
12.5 Biocon Ltd.
Exhibit 128: Biocon Ltd. - Overview
Exhibit 129: Biocon Ltd. - Business segments
Exhibit 130: Biocon Ltd. - Key offerings
Exhibit 131: Biocon Ltd. - Segment focus
12.6 Eli Lilly and Co.
Exhibit 132: Eli Lilly and Co. - Overview
Exhibit 133: Eli Lilly and Co. - Product / Service
Exhibit 134: Eli Lilly and Co. - Key news
Exhibit 135: Eli Lilly and Co. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Gerresheimer AG
Exhibit 141: Gerresheimer AG - Overview
Exhibit 142: Gerresheimer AG - Business segments
Exhibit 143: Gerresheimer AG - Key news
Exhibit 144: Gerresheimer AG - Key offerings
Exhibit 145: Gerresheimer AG - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 146: GlaxoSmithKline Plc - Overview
Exhibit 147: GlaxoSmithKline Plc - Business segments
Exhibit 148: GlaxoSmithKline Plc - Key news
Exhibit 149: GlaxoSmithKline Plc - Key offerings
Exhibit 150: GlaxoSmithKline Plc - Segment focus
12.10 Merck KGaA
Exhibit 151: Merck KGaA - Overview
Exhibit 152: Merck KGaA - Business segments
Exhibit 153: Merck KGaA - Key news
Exhibit 154: Merck KGaA - Key offerings
Exhibit 155: Merck KGaA - Segment focus
12.11 Novartis AG
Exhibit 156: Novartis AG - Overview
Exhibit 157: Novartis AG - Business segments
Exhibit 158: Novartis AG - Key offerings
Exhibit 159: Novartis AG - Segment focus
12.12 Novo Nordisk AS
Exhibit 160: Novo Nordisk AS - Overview
Exhibit 161: Novo Nordisk AS - Business segments
Exhibit 162: Novo Nordisk AS - Key offerings
Exhibit 163: Novo Nordisk AS - Segment focus
12.13 Owen Mumford Ltd.
Exhibit 164: Owen Mumford Ltd. - Overview
Exhibit 165: Owen Mumford Ltd. - Product / Service
Exhibit 166: Owen Mumford Ltd. - Key offerings
12.14 Pfizer Inc.
Exhibit 167: Pfizer Inc. - Overview
Exhibit 168: Pfizer Inc. - Product / Service
Exhibit 169: Pfizer Inc. - Key news
Exhibit 170: Pfizer Inc. - Key offerings
12.15 Sanofi
Exhibit 171: Sanofi - Overview
Exhibit 172: Sanofi - Business segments
Exhibit 173: Sanofi - Key news
Exhibit 174: Sanofi - Key offerings
Exhibit 175: Sanofi - Segment focus
12.16 Viatris Inc.
Exhibit 176: Viatris Inc. - Overview
Exhibit 177: Viatris Inc. - Business segments
Exhibit 178: Viatris Inc. - Key news
Exhibit 179: Viatris Inc. - Key offerings
Exhibit 180: Viatris Inc. - Segment focus
12.17 Ypsomed Holding AG
Exhibit 181: Ypsomed Holding AG - Overview
Exhibit 182: Ypsomed Holding AG - Business segments
Exhibit 183: Ypsomed Holding AG - Key offerings
Exhibit 184: Ypsomed Holding AG - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations